leucine-rich a-2-glycoprotein 1

ETTAC-2 acetate is a selective PROTAC degrader targeting LRG1 (Leucine-rich α-2 glycoprotein 1), inhibiting the TGF-β-Smad3 signalling pathway to slow renal fibrosis progression.

ETTAC-2 是一种LRG1PROTAC降解剂，能够促进LRG1的泛素化和降解 (DC50为8.38 µM)。它抑制TGF-β-Smad3信号通路，减少与纤维化相关的蛋白分泌，并能有效减缓肾纤维化的进展。